Dual antiplatelet therapy in patients with diabetes mellitus: special considerations.

about

Dual antiplatelet therapy in patients with diabetes mellitus: special considerations.

Item

http://www.wikidata.org/entity/Q38087381

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Dual antiplatelet therapy in patients with diabetes mellitus: special considerations.

@en

type

Item

label

Dual antiplatelet therapy in patients with diabetes mellitus: special considerations.

@en

prefLabel

Dual antiplatelet therapy in patients with diabetes mellitus: special considerations.

@en

P1476

Dual antiplatelet therapy in patients with diabetes mellitus: special considerations.

@en

P2093

Piera Capranzano

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study

Cyclooxygenase-1 haplotype modulates platelet response to aspirin

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

P304

307-317

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERC.13.3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Davide Capodanno

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23469911

http://www.w3.org/2001/XMLSchema#string